A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of JSP191 for Hematopoietic Cell Transplantation Conditioning to Achieve Engraftment and Immune Reconstitution in Subjects With SCID

Disease Name: 
Severe Combined Immune Deficiency Syndrome (SCID)
Study Status: 
Recruiting
Date: 
April 25, 2023
Detail Link ( on-site link ): 
/phase-12-study-evaluate-safety-tolerability-and-efficacy-jsp191-hematopoietic-c…